Atlas Trials

Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients

Clinical trial NCT04888312 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04888312
Sponsor
Alligator Bioscience AB
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic Ductal Adenocarcinoma
Start date
2021-09-17
Primary completion
2026-06-01
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.